The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...
The authors assessed the patient characteristics associated with RSV vaccination among older adults hospitalized during the ...
Older adults and people with certain medical conditions are more likely to receive the respiratory syncytial virus (RSV) ...
More than 190,000 people still sought medical help for acute respiratory infection (ARI), including 30,000 with ...
Zacks Investment Research on MSN1d
PFE Secures EU Nod for Expanded Use of RSV Vaccine AbrysvoPfizer PFE announced that the European Commission (“EC”) has granted marketing authorization to expand the use of its RSV ...
Pharmaceutical Technology on MSN2d
Pfizer’s RSV vaccine wins expanded approval in EU, gaining edge over GSKAbrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...
Children aged 6 months to 12 years are the main spreaders of respiratory syncytial virus (RSV) infections within their ...
COVID, flu and RSV levels have already hit their peaks. (Pollen levels and springtime allergies are a whole different story.) ...
The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing ...
New Jersey joined 22 states suing the Trump administration to stop its plan to cut more than $11 billion in funding for ...
GRAND JUNCTION, Colo. (KJCT) -Mesa County Public Health released the latest respiratory illness trends. Data showed the hospitalization rate for Covid-19, flu and RSV dropped from March 18th. The data ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback